Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
6
×
indiana blog main
indiana top stories
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
6
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
eli lilly
ipo
merck
nivolumab
renaissance capital
abbvie
alzheimer's disease
astrazeneca
biogen
What
week
6
×
bio
ipo
life
roundup
science
companies
biotechs
firms
moves
public
therapeutics
alzheimer’s
america
annual
arena’s
assessed
attention
biogen
biotech
black
bounty
chose
cig
close
club
comeback
communities
company
conference
continue
continued
continues
convoluted
corner
crop
deals
debut
delivered
democrats
Language
unset
Current search:
fda
×
biotech
×
" raleigh-durham top stories "
×
" indiana top stories "
×
week
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M